Analysis of two additional neuroblastoma cell lines revealed reduced Bcl-2 protein levels upon treatment with I-BET726 (Figure 6D), confirming the critical role of BET proteins in maintaining BCL2 expression. This evidence concerns the gene BCL2 and neuroblastoma.